NHI Amends Director and Officer Filings

Ticker: NHI · Form: 8-K/A · Filed: Jan 8, 2025 · CIK: 877860

Sentiment: neutral

Topics: amendment, director-changes, officer-compensation

Related Tickers: NHI

TL;DR

NHI filed an amendment to its 8-K, updating director changes and executive pay details.

AI Summary

National Health Investors Inc. filed an 8-K/A on January 8, 2025, to amend a previous filing. The amendment pertains to the departure of a director, election of a new director, and changes in compensatory arrangements for certain officers, effective December 2, 2024.

Why It Matters

This filing provides updated information on the company's leadership and executive compensation, which can impact investor confidence and strategic direction.

Risk Assessment

Risk Level: low — This is an amendment to a previous filing, primarily providing updated administrative and personnel information without introducing new financial risks.

Key Players & Entities

FAQ

What specific items are being amended in this 8-K/A filing?

This 8-K/A amends information regarding the departure of a director, the election of a director, and compensatory arrangements for certain officers.

When were the changes reported in this amendment effective?

The changes reported in this amendment were effective as of December 2, 2024.

What is the company's principal executive office address?

The company's principal executive offices are located at 222 Robert Rose Drive, Murfreesboro, TN 37129.

What is the Commission File Number for National Health Investors Inc.?

The Commission File Number for National Health Investors Inc. is 001-10822.

What is the Standard Industrial Classification (SIC) code for National Health Investors Inc.?

The Standard Industrial Classification (SIC) code for National Health Investors Inc. is 6798, which corresponds to Real Estate Investment Trusts.

Filing Stats: 679 words · 3 min read · ~2 pages · Grade level 10.8 · Accepted 2025-01-08 16:16:22

Key Financial Figures

Filing Documents

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. Exhibit Index Number Exhibit 104 Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. NATIONAL HEALTH INVESTORS, INC. By: /s/ John L. Spaid Name: John L. Spaid Title: Principal Financial Officer Date: January 8, 2025

View Full Filing

View this 8-K/A filing on SEC EDGAR

View on Read The Filing